Scribd
Upload
70 views10 pages

An Insight To Pharma Industry : Rajni Bansal

Uploaded by

vikas_chahal8373
Copyright
© Attribution Non-Commercial (BY-NC)
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPT, PDF, TXT or read online on Scribd
70 views10 pages

An Insight To Pharma Industry : Rajni Bansal

Uploaded by

vikas_chahal8373
Copyright
© Attribution Non-Commercial (BY-NC)
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPT, PDF, TXT or read online on Scribd
You are on page 1/ 10

An Insight to Pharma Industry…

Rajni Bansal
About Pharma Industry…
• Pharmaceutical industry develops, produces,
and markets drugs licensed for use
as medications.
• Pharmaceutical companies are allowed to deal
in generic and/or brand medications and
medical devices.
• They are subject to a variety of laws and
regulations regarding the patenting, testing
and ensuring safety and efficacy
and marketing of drugs.
Johnson & Johnson

Its new prostate cancer drug, Zytiga, won the


FDA's nod for patients who've previously
received chemotherapy. Analysts predict the drug
will generate $800 million to more than $1 billion
in annual sales.
Lilly and Medtronic Announce Drug-Device
Collaboration for Parkinson's Disease

Eli Lilly & Company and Medtronic have


entered into a collaboration to R&D a new
approach to treating Parkinson's disease that
involves delivering a potential new medicine
to the brain using an implantable drug
delivery system.
Goal of the collaboration is to develop a
therapeutic approach for Parkinson's disease.
Pfizer Inc. announced top-line results from
the ORAL Standard (A3921064) and ORAL
Step (A3921032) Phase 3 studies of
tofacitinib.

• ORAL Standard is a completed twelve-


month study in patients with moderate-to-
severe active rheumatoid arthritis.
• Oral Step is a completed six-month study in
patients.
Bristol-Myers Squibb Delivers
Excellent First Quarter with
YERVOY™ Approval

Bristol-Myers Squibb Company announced


first quarter results that included strong sales
and earnings growth, and several key R&D
milestones - most notably U.S. regulatory
approval for YERVOY.
Future Prospects
 McKinsey & Company stated in a report title “India
Pharma 2020”: The Indian pharmaceuticals market is
expected to reach US$ 55 billion in 2020 from US$ 12.6
billion in 2009.
 Ernst & Young stated that due to increase in the
population of high income group, there is every likelihood
that they will open a potential US$ 8 billion market for
multinational companies selling costly drugs by 2015.
 The sale of all types of pharmaceutical drugs and
medicines in the country stands at US$ 9.61 billion,
which is expected to reach around US$ 19.22 billion by
2012.
Budget 2011
 Pharma firms want tax cuts, R&D sops boost. – Drug
makers want tax exemption deadline for export oriented
unit (EOUs) to be extended and want infrastructure or
priority sector status in the budget on Feb 28.
 The exemption beyond March 2011 will provide relief to
companies like Dishman Pharmaceuticals & Chemicals,
Cipla and Torrent Pharmaceuticals , which run EOUs.
 The government may grant infrastructure or priority
sector status to healthcare, which would help draw more
investments and lower costs,
Economic Times says…
 Medical bills will increase by 5%, as the Budget has
levied service tax on hospital and diagnostic service
providers. Pharmaceutical sector has expressed relief
over continuation of concessions on excise duty
provided during the global economic meltdown.
 Centralised air conditioned (AC) hospitals with more than
25 beds and even diagnostic service providers are
brought under 10% service tax.
Thank you…

You might also like